BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Badr-eldin SM, Aldawsari HM, Alhakamy NA, Fahmy UA, Ahmed OAA, Neamatallah T, Tima S, Almaghrabi RH, Alkudsi FM, Alamoudi AA, Alzahrani AA, Kotta S, Al-hejaili OD. Merging Experimental Design and Nanotechnology for the Development of Optimized Simvastatin Spanlastics: A Promising Combined Strategy for Augmenting the Suppression of Various Human Cancer Cells. Pharmaceutics 2022;14:1024. [DOI: 10.3390/pharmaceutics14051024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdelmonem R, Al-Samadi IEI, El Nashar RM, Jasti BR, El-Nabarawi MA. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Drug Deliv 2022;29:2868-82. [PMID: 36065090 DOI: 10.1080/10717544.2022.2115164] [Reference Citation Analysis]
2 Alharbi WS, Hareeri RH, Bazuhair M, Alfaleh MA, Alhakamy NA, Fahmy UA, Alamoudi AA, Badr-Eldin SM, Ahmed OA, AlGhamdi SA, Naguib MJ. Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment. Pharmaceutics 2022;14. [PMID: 36559120 DOI: 10.3390/pharmaceutics14122627] [Reference Citation Analysis]